FindTrial
Sign In

Estimation of levels of Serum neurofilament light chains in leprosy patients with peripheral neuropathy

Assessment of serum neurofilament light chains in leprosy associated peripheral neuropathy - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/065814
Enrollment
70
Registered
2024-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A309- Leprosy, unspecified

Interventions

Intervention1: NIL: NIL Intervention2: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Indian Association of Dermatology, Venereology and Leprosy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult Patients diagnosed with leprosy with and without peripheral neuropathy. 2. Age and sex matched healthy controls.

Exclusion criteria

Exclusion criteria: 1. Any alternate diagnosis of peripheral neuropathy 2. Presence of diabetes 3. History of chronic alcoholism

Design outcomes

Primary

MeasureTime frame
To assess the serum levels of neurofilament light chains in patients with peripheral neuropathy of leprosy and compare it with levels in patients of leprosy without peripheral neuropathy, and healthy controlsTimepoint: 6 months—

Secondary

MeasureTime frame
To understand the role of neurofilament light chains in the early detection of peripheral neuropathy in leprosy patientsTimepoint: 6 months—

Countries

India

Contacts

Public ContactAnanta Khurana

Atal Bihari Vajpayee Institute of Medical Sciences and Dr Ram Manohar Lohia Hospital

drananta2014@gmail.com9212370467

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026